MMP20
protein-codingmatrix metallopeptidase 20, the group of M10 matrix metallopeptidases
Gene summary
Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The protein encoded by this gene degrades amelogenin, the major protein component of dental enamel matrix, and thus thought to play a role in tooth enamel formation. A mutation in this gene, which alters the normal splice pattern and results in premature termination of the encoded protein, has been associated with amelogenesis imperfecta. This gene is part of a cluster of MMP genes located on chromosome 11q22.3. [provided by RefSeq, Aug 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~48.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0012926
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0015048
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0012926
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0012926
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Dental
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MMP20 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004771.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 14 | 5 | 1 | 20 | ||
| missense | 4 | 3 | 104 | 9 | 1 | 121 |
| nonsense | 1 | 3 | 4 | |||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | |||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 7 | 7 | 119 | 14 | 2 | 149 |
Highest pathogenic variant AF is 0.0023370972
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004762.2 | 10 | MANE Select | |
| Ensembl | ENSP00000260228.2 | 10 | MANE Select |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Matrix Metalloproteinases
- Assembly of collagen fibrils and other multimeric structures
- Collagen degradation
- Collagen formation
- Extracellular matrix organization
Biological Process
- proteolysis
- extracellular matrix disassembly
- protein catabolic process
- extracellular matrix organization
- collagen catabolic process
Molecular Function
- metalloendopeptidase activity
- serine-type endopeptidase activity
- protein binding
- zinc ion binding
Cellular Component
- extracellular region
- extracellular space
- extracellular matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000260228
- Coding exons
- 10
- Length
- 48498
- Individuals with no LoFs
- 125422
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 326
- Defined
- 125748
- p
- 0.00130
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.567 | 301 | 275 | 1.10 | 0.0000152 | 3172 |
| Missense (PolyPhen) | 96 | 94.936 | 1.0112 | 1064 | ||
| Synonymous | -1.75 | 126 | 103 | 1.22 | 0.00000619 | 930 |
| Loss of Function | 0.222 | 21 | 22.1 | 0.949 | 9.41e-7 | 285 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00045 | 0.00043 | rare |
| Latino/Admixed American | 0.0014 | 0.0013 | notable |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00076 | 0.00076 | rare |
| Finnish | 0.00023 | 0.00023 | rare |
| European (Non-Finnish) | 0.0021 | 0.0020 | notable |
| South Asian | 0.00042 | 0.00042 | rare |
| Other | 0.0021 | 0.0020 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Degrades amelogenin, the major protein component of the enamel matrix and two of the macromolecules characterizing the cartilage extracellular matrix: aggrecan and the cartilage oligomeric matrix protein (COMP). May play a central role in tooth enamel formation. Cleaves aggrecan at the '360-Asn-|-Phe-361' site. {ECO:0000269|PubMed:10922468, ECO:0000269|PubMed:9398237}.;
- Disease
- DISEASE: Amelogenesis imperfecta, hypomaturation type, 2A2 (AI2A2) [MIM:612529]: A defect of enamel formation. The disorder involves both primary and secondary dentitions. The teeth have a shiny agar jelly appearance and the enamel is softer than normal. Brown pigment is present in middle layers of enamel. {ECO:0000269|PubMed:15744043}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.141
Intolerance Scores
- LoFtool
- 0.714
- RVIS EVS
- 1.42
- RVIS percentile EVS
- 94.97
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0774
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |